Pervasis Picks Up $9.75 Million

Cambridge, MA-based regenerative medicine firm Pervasis Therapeutics has raised $9.75 million in new funding from Flagship Venture Partners, Polaris Venture Partners, Highland Capital Partners, and Musket Research Associates, the firm announced today. Pervasis will use the funds to further the development of Vascugel, a blood-vessel-repair product, as well as research into other applications of its technology.

Rebecca is Xconomy's co-founder. Follow @

Trending on Xconomy